TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

NCT00185796 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Myeloproliferative Disorders
Blood Cancer
Myelodysplastic Syndromes

Interventions

PROCEDURE: Total Lymphoid Irradiation (TLI)
PROCEDURE: Anti-Thymocyte Globulin as Conditioning (ATG)

Sponsor

Stanford University

Collaborators

[object Object]